All filters
Abstracts
Eu HIV & Hep Abstracts 2022_56
L. Ramirez Reviews in Antiviral Therapy & Infectious Diseases 3, 2022
Presented at:
European Meeting on HIV & Hepatitis 2022
Abstracts
Prevalence and viral load suppression rate among children and adolescents with dual infections (any two of HIV, HBV, and HCV) in Nnewi, Nigeria
S. Kalu Reviews in Antiviral Therapy & Infectious Diseases 3, 2022
Presented at:
European Meeting on HIV & Hepatitis 2022
Abstracts
Proviral DNA for detection of HIV-1 subtype A drug resistance mutations
D. Turner Reviews in Antiviral Therapy & Infectious Diseases 3, 2022
Presented at:
European Meeting on HIV & Hepatitis 2022
Abstracts
Combined COVID-19 vaccination and hepatitis C virus screening intervention for high-risk populations at a centre for addiction services in Barcelona, Spain
J. Lazarus Reviews in Antiviral Therapy & Infectious Diseases 3, 2022
Presented at:
European Meeting on HIV & Hepatitis 2022
Abstracts
Combined COVID-19 vaccination and hepatitis C virus and HIV screening intervention for high- risk populations at a mobile testing unit in Madrid, Spain
J. Lazarus Reviews in Antiviral Therapy & Infectious Diseases 3, 2022
Presented at:
European Meeting on HIV & Hepatitis 2022
Abstracts
Community perspectives on self- testing for HIV and HCV in the WHO European region
S. North Reviews in Antiviral Therapy & Infectious Diseases 3, 2022
Presented at:
European Meeting on HIV & Hepatitis 2022
Abstracts
Viral load suppression after three-year Ibalizumab treatment in a multidrug-resistant HIV-1- infected woman: Clinical experience.
I. Santos Reviews in Antiviral Therapy & Infectious Diseases 3, 2022
Presented at:
European Meeting on HIV & Hepatitis 2022
Abstracts
CASE - HIV+ End-Stage Renal Disease Patient with Immunosuppressive Drug-Drug Interactions Received Successful Transplantation after Ibalizumab Suppressed Switch
S. Sharma Reviews in Antiviral Therapy & Infectious Diseases 3, 2022
Presented at:
European Meeting on HIV & Hepatitis 2022
Abstracts
Clinical course of AIDS with COVID-19 coinfection with prolonged SARS CoV-2 replication despite remdesivir/molnupiravir treatment.
B. Aksak-Wąs Reviews in Antiviral Therapy & Infectious Diseases 3, 2022
Presented at:
European Meeting on HIV & Hepatitis 2022
Abstracts
A Case of IRIS Syphilis Due to Prozone Effect
Y. Rahman Reviews in Antiviral Therapy & Infectious Diseases 3, 2022
Presented at:
European Meeting on HIV & Hepatitis 2022
Slidesets
Fatal Triple – Linking Obesity, Type-2 Diabetes, and NASH - Cyrielle Caussy, MD, PhD slides
Presented at:
Innovations in NAFLD Care Workshop 2022
Meeting
Conference on Liver Disease in Africa (COLDA) 2021
9 Sep 2021 - 11 Sep 2021
Virtual Meeting
Meeting
Central and Eastern European Meeting on Viral Hepatitis and HIV 2021
14 Oct 2021 - 15 Oct 2021
Virtual Meeting
Meeting
International Viral Hepatitis Elimination Meeting (IVHEM) 2021
3 Dec 2021 - 4 Dec 2021
Virtual Meeting
Slidesets
Slide: Progress Towards Hepatitis C (HCV) Elimination in Punjab, India: An Update - Karan Singla
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2021
Videos
Progress Towards Hepatitis C (HCV) Elimination in Punjab, India: An Update - Karan Singla
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2021
Videos
Viral Hepatitis Elimination Status in India - Shiv Sarin , MD, DM
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2021
Videos
Video: Viral Hepatitis Elimination Status in China, Liang Xiaofeng, MD
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2021